JPRN-UMIN000023620已完成未知
Clinical research of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytology - PR-PHOENIX trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Distal metastasis other than to the peritoneum, ovary and abdominal lymph nodes 2) Contraindication to S-1 or paclitaxel 3) Apparent infection or inflammation 4) Severe heart disease 5) Severe complication 6) Gastrointestinal tract bleeding requiring blood transfusion 7) Pregnancy, breast feeding or intention to become pregnant 8) Judged inappropriate for this trial for other reasons
研究者
相似试验
已完成
2 期
PR-PHOENIX trialgastric cancer with peritoneal metastasis or positive peritoneal cytologyJPRN-jRCTs031180025Ishigami Hironori121
已完成
不适用
Clinical trial of S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis or positive peritoneal cytologyGastric cancer with peritoneal metastasis or positive peritoneal cytology.JPRN-UMIN000027389Tottori University Hospital15
已完成
不适用
Phase I/II study of S-1 plus intravenous and intraperitoneal paclitaxel for pancreas cancer with peritoneal metastasisThe patients with pancreatic cancer who have peritoneal metastasis diagnosed by staging laparoscopy or open laparotomy.JPRN-UMIN000009446Study group of pancreatic cancer with peritoneal metastasis33
招募中
不适用
Phase III study of S-1 plus intravenous and introperitoneal paclitaxel for pancreatic ductal adenocarcinoma patients with peritoneal metastasispancreatic ductal adenocarcinoma patients with peritoneal metastasisJPRN-UMIN000027229Study group of pancreatic cancer with peritoneal metastasis180
已完成
3 期
Phase III study of S-1 plus intravenous and intraperitoneal paclitaxel versus S-1 plus cisplatin for gastric cancer with peritoneal metastasisgastric cancer with peritoneal metastasisJPRN-UMIN000005930The University of Tokyo Hospital180